Navigation Links
ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011
Date:6/17/2011

PHILADELPHIA, June 17, 2011 /PRNewswire/ -- ERT (NASDAQ: ERT), announced today that Keith Schneck, the Company's Chief Financial Officer, is scheduled to present at the 2011 Wells Fargo Securities Healthcare Conference at 1:30 PM ET on Thursday, June 23, 2011 in Boston.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com. The webcast may also be accessed at http://cc.talkpoint.com/well001/062211a_cy/?entity=46_YPI335L.  The webcast will be available via replay for 90 days.

About ERT

ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic Patient Reported Outcomes (ePRO) in multiple modalities across all phases of clinical research.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly up
'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
(Date:1/15/2014)... Pharmaceuticals International, Inc. (NYSE: VRX and ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with ... indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all ... Medical, Inc. (NASDAQ: SLTM ) ("Solta") at ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
(Date:4/18/2014)... Northwestern Medicine scientists could lead to potential new treatments ... with scleroderma. , Fibrosis, or scarring, is a ... skin and lungs can lead to serious organ damage ... new therapeutic options centers on findings made by Swati ... the role that a specific protein plays in promoting ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
(Date:4/17/2014)... Researchers at the University of California, San Diego School ... those who have suffered a recent major loss are ... older adults. , The study is published in this ... Psychiatry . , Because compassionate behaviors are associated with ... findings offer insights into ways to improve the outcomes ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:New pain relief targets discovered 2Health News:Study sheds light on how the immune system protects children from malaria 2Health News:The ilk of human kindness 2
... as other adults to attempt to end own life, study finds ... at birth are more likely to attempt suicide and more than ... normal-length newborns, a new study says. , Violent suicide includes hanging, ... height or in front of a vehicle, or drowning. , The ...
... COMPTCHE, Calif., Jan. 25 Wild Iris ... for healthcare professionals,( http://www.wildirismedicaleducation.com ) has just ... and more HMOs turn to telephone nursing ... health-related,problems by trained RNs using guidelines or ...
... Bmed, Ronit Calderon-Margalit, MD, MPH, Marianna Mazar, MD and ... to Jewish and Arab diabetes sufferers who were admitted ... evaluate whether differences existed between the two groups and, ... of health insurance coverage. The researchers found significant differences. ...
... following statement about next Monday,s vote on the health care,reform ... State Senate,Committee on Health:, "On behalf of AARP and ... the State Senate Health Committee to pass ABX 1 1 ... 1 represents a major step toward,ensuring that every Californian has ...
... 25 Super Bowl Sunday,s almost here-and,what better time ... losing some weight. Right? As more than 90 million ... event of the year, we,plan parties predicting the collapse ... With those big-guy pro,s gearing up for Super Bowl ...
... LOS ANGELES, Jan. 25 An unprecedented move,by ... it came to the table to settle two class ... Dec. 21, 2007 in Orange,County Superior Court, and one ... the Multnomah County Circuit Court and,should receive final approval ...
Cached Medicine News:Health News:Short Birth Length Boosts Men's Suicide Risk 2Health News:Telephone Nursing an Important Component of Managed Healthcare 2Health News:Super Bowl and SuperFoods: Play Smart 2Health News:Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit 2Health News:Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit 3
... visual field testing that's so efficient it,can ... first visual field instrument that's simple enough, ... used even in pre-test. Affordably priced FDT ... behind it to validate performance. The instrument ...
... Gore's EXCLUDER AAA Endoprosthesis is an innovative ... treatment option for patients with abdominal aortic ... durable ePTFE bifurcated graft with an outer ... device flexibility and material durability. The function ...
... (formerly sold as GORE Cast Liner) enables ... minimizing discomfort and other cast related nuisances. ... breathable, washable cast padding that replaces the ... cast. It allows patients the freedom to ...
... grafting or creation of a vascular access, ... is of the utmost importance in many ... for those seeking a high-precision tunneling instrument. ... risk of twisting or kinking for more ...
Medicine Products: